Fong-Pin Liang,1,* Jin-Cherng Lien,1,* Yu-Hua Wu,2 Chien-Shu Chen,2 Shin-Hun Juang1–3 1Graduate Institute of Pharmaceutical Chemistry, 2School of Pharmacy and Department of Pediatrics, Children’s Hospital, 3Department of Medical Research, China Medical University Hospital, Taichung, Taiwan *These authors contributed equally to this work Abstract: Expression of ErbB2 protein is inversely correlated with the prognosis in cancer patients. Consequently, strategies targeting ErbB2 remain an attractive option in treating several types of malignancies, including oral cancer. In addition, many studies have shown that emodin and emodin derivatives are able to inhibit growth of ErbB2-overexpressing tumor cells. In this study, a series ...
Background: Chemoresistance is one of the most leading causes for tumor progression and recurrence o...
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural occurring anthraquinone derivative isol...
Many human diseases, including cancers, result from aberrations of signal transduction pathways. The...
[[abstract]]Emodin, an active natural anthraquinone derivative, is found in the roots and rhizomes o...
[[abstract]]Emodin was isolated from Rheum palmatum L. and exhibits an anticancer effect on human ca...
Emodin is a cell arrest and apoptosis-inducing compound that is widely distributed in different plan...
[[abstract]]Emodin was isolated from Rheum palmatum L. and exhibits an anticancer effect on human ca...
[[abstract]]Emodin was isolated from Rheum palmatum L. and exhibits an anticancer effect on human ca...
Emodin, a major component of rhubarb, has anti-tumor effects in a variety of cancers, influencing mu...
Purpose: To determine the anticancer effects of emodin in human esophageal carcinoma cell line ECA10...
Renal cell carcinoma (RCC) is a tumor with unpredictable presentation and poor clinical outcome. RCC...
Context: The poor prognostic outcome of breast cancer is largely due to its resistance to cancer the...
Recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is currently under clini...
[[abstract]]Emodin—a major component of Rheum palmatum L.—exerts antiproliferative effects in cancer...
Emodin (1,3,8-trihydroxy-6-methylanthraquinone), a major constituent of rhubarb, has a wide range of...
Background: Chemoresistance is one of the most leading causes for tumor progression and recurrence o...
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural occurring anthraquinone derivative isol...
Many human diseases, including cancers, result from aberrations of signal transduction pathways. The...
[[abstract]]Emodin, an active natural anthraquinone derivative, is found in the roots and rhizomes o...
[[abstract]]Emodin was isolated from Rheum palmatum L. and exhibits an anticancer effect on human ca...
Emodin is a cell arrest and apoptosis-inducing compound that is widely distributed in different plan...
[[abstract]]Emodin was isolated from Rheum palmatum L. and exhibits an anticancer effect on human ca...
[[abstract]]Emodin was isolated from Rheum palmatum L. and exhibits an anticancer effect on human ca...
Emodin, a major component of rhubarb, has anti-tumor effects in a variety of cancers, influencing mu...
Purpose: To determine the anticancer effects of emodin in human esophageal carcinoma cell line ECA10...
Renal cell carcinoma (RCC) is a tumor with unpredictable presentation and poor clinical outcome. RCC...
Context: The poor prognostic outcome of breast cancer is largely due to its resistance to cancer the...
Recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is currently under clini...
[[abstract]]Emodin—a major component of Rheum palmatum L.—exerts antiproliferative effects in cancer...
Emodin (1,3,8-trihydroxy-6-methylanthraquinone), a major constituent of rhubarb, has a wide range of...
Background: Chemoresistance is one of the most leading causes for tumor progression and recurrence o...
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural occurring anthraquinone derivative isol...
Many human diseases, including cancers, result from aberrations of signal transduction pathways. The...